| 流式1.EMBO molecular medicineProlonged contact with dendritic cells turns lymph node-resident NK cells into anti-tumor effectors."16-6507 was used in Flow cytometry/Cell sorting to understand natural killer cell activation dynamics, interactions with accessory cells, and trafficking between secondary lymphoid organs and tumoural tissues."AuthorsMingozzi F,Spreafico R,Gorletta T,Cigni C,Di Gioia M,Caccia M,Sironi L,Collini M,Soncini M,Rusconi M,von Andrian UH,Chirico G,Zanoni I,Granucci F功能检测2.Scientific reportsInterleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells."16-6507 was used in Neutralization experiments to investigate the role of IL-37 in cancer."AuthorsZhao JJ,Pan QZ,Pan K,Weng DS,Wang QJ,Li JJ,Lv L,Wang DD,Zheng HX,Jiang SS,Zhang XF,Xia JC3.PLoS pathogensBlock of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts."16-6507 was used in Neutralization experiments to investigate the role of death-receptor blockade in cytomegalovirus infection."AuthorsEbermann L,Ruzsics Z,Guzmán CA,van Rooijen N,Casalegno-Garduño R,Koszinowski U,Čičin-Šain L中和4.CancersTargeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer."16-6507 was used in in vivo experiments to investigate the use of retired self-proteins in the treatment of cancer, showing that vaccination against α-Lactalbumin can be used against triple negative breast cancers."AuthorsTuohy VK,Jaini R,Johnson JM,Loya MG,Wilk D,Downs-Kelly E,Mazumder S |
QQ:1749072012